BVNKF
Price
$29.27
Change
+$0.17 (+0.58%)
Updated
Nov 28 closing price
Capitalization
2.34B
Intraday BUY SELL Signals
CVALF
Price
$1.37
Change
+$0.02 (+1.48%)
Updated
Dec 2 closing price
Capitalization
38.27M
Intraday BUY SELL Signals
Interact to see
Advertisement

BVNKF vs CVALF

Header iconBVNKF vs CVALF Comparison
Open Charts BVNKF vs CVALFBanner chart's image
Bavarian Nordic A/S
Price$29.27
Change+$0.17 (+0.58%)
Volume$250
Capitalization2.34B
Covalon Technologies
Price$1.37
Change+$0.02 (+1.48%)
Volume$4K
Capitalization38.27M
BVNKF vs CVALF Comparison Chart in %
BVNKF
Daily Signal:
Gain/Loss:
CVALF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BVNKF vs. CVALF commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVNKF is a Hold and CVALF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BVNKF: $29.26 vs. CVALF: $1.35)
Brand notoriety: BVNKF and CVALF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVNKF: 46% vs. CVALF: 12%
Market capitalization -- BVNKF: $2.25B vs. CVALF: $37.68M
BVNKF [@Biotechnology] is valued at $2.25B. CVALF’s [@Biotechnology] market capitalization is $37.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVNKF’s FA Score shows that 0 FA rating(s) are green whileCVALF’s FA Score has 0 green FA rating(s).

  • BVNKF’s FA Score: 0 green, 5 red.
  • CVALF’s FA Score: 0 green, 5 red.
According to our system of comparison, BVNKF is a better buy in the long-term than CVALF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BVNKF’s TA Score shows that 3 TA indicator(s) are bullish while CVALF’s TA Score has 3 bullish TA indicator(s).

  • BVNKF’s TA Score: 3 bullish, 5 bearish.
  • CVALF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CVALF is a better buy in the short-term than BVNKF.

Price Growth

BVNKF (@Biotechnology) experienced а +0.60% price change this week, while CVALF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BVNKF($2.34B) has a higher market cap than CVALF($38.3M). CVALF has higher P/E ratio than BVNKF: CVALF (21.24) vs BVNKF (6.12). BVNKF YTD gains are higher at: 11.231 vs. CVALF (-39.732). BVNKF has higher annual earnings (EBITDA): 2.12B vs. CVALF (3.14M). BVNKF has more cash in the bank: 1.66B vs. CVALF (18.1M). CVALF has less debt than BVNKF: CVALF (1.28M) vs BVNKF (136M). BVNKF has higher revenues than CVALF: BVNKF (6.46B) vs CVALF (33M).
BVNKFCVALFBVNKF / CVALF
Capitalization2.34B38.3M6,115%
EBITDA2.12B3.14M67,399%
Gain YTD11.231-39.732-28%
P/E Ratio6.1221.2429%
Revenue6.46B33M19,561%
Total Cash1.66B18.1M9,188%
Total Debt136M1.28M10,642%
FUNDAMENTALS RATINGS
BVNKF vs CVALF: Fundamental Ratings
BVNKF
CVALF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
6174
PRICE GROWTH RATING
1..100
6486
P/E GROWTH RATING
1..100
9479
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BVNKF's Valuation (46) in the null industry is in the same range as CVALF (70). This means that BVNKF’s stock grew similarly to CVALF’s over the last 12 months.

CVALF's Profit vs Risk Rating (77) in the null industry is in the same range as BVNKF (100). This means that CVALF’s stock grew similarly to BVNKF’s over the last 12 months.

BVNKF's SMR Rating (61) in the null industry is in the same range as CVALF (74). This means that BVNKF’s stock grew similarly to CVALF’s over the last 12 months.

BVNKF's Price Growth Rating (64) in the null industry is in the same range as CVALF (86). This means that BVNKF’s stock grew similarly to CVALF’s over the last 12 months.

CVALF's P/E Growth Rating (79) in the null industry is in the same range as BVNKF (94). This means that CVALF’s stock grew similarly to BVNKF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BVNKFCVALF
RSI
ODDS (%)
Bullish Trend 6 days ago
45%
Bullish Trend 6 days ago
62%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
49%
Bullish Trend 6 days ago
62%
Momentum
ODDS (%)
Bearish Trend 6 days ago
57%
Bullish Trend 6 days ago
58%
MACD
ODDS (%)
Bearish Trend 6 days ago
53%
Bearish Trend 6 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
58%
Bearish Trend 6 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
56%
Bearish Trend 6 days ago
63%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
54%
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
68%
Bearish Trend 6 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
BVNKF
Daily Signal:
Gain/Loss:
CVALF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKRBY12.15N/A
N/A
Aker BP Asa
HSTA0.05N/A
N/A
Hestia Insight Inc.
SOHVY6.60N/A
N/A
Sumitomo Heavy Industries Co.
MSCH0.11N/A
N/A
MainStreetChamber Holdings Inc.
ITFS2.15N/A
N/A
ITAFOS INC.

BVNKF and

Correlation & Price change

A.I.dvisor tells us that BVNKF and LABFF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVNKF and LABFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVNKF
1D Price
Change %
BVNKF100%
N/A
LABFF - BVNKF
24%
Poorly correlated
N/A
SILO - BVNKF
22%
Poorly correlated
-0.96%
GOVX - BVNKF
22%
Poorly correlated
-0.77%
MBXBF - BVNKF
21%
Poorly correlated
N/A
IMRN - BVNKF
20%
Poorly correlated
-0.58%
More

CVALF and

Correlation & Price change

A.I.dvisor tells us that CVALF and SMMT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVALF and SMMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVALF
1D Price
Change %
CVALF100%
N/A
SMMT - CVALF
27%
Poorly correlated
N/A
AKBLF - CVALF
21%
Poorly correlated
N/A
TARA - CVALF
21%
Poorly correlated
-7.79%
MBIO - CVALF
20%
Poorly correlated
-7.69%
BVNKF - CVALF
11%
Poorly correlated
N/A
More